Metis Global Partners LLC Raises Stock Position in Healthcare Realty Trust Incorporated (NYSE:HR)

Metis Global Partners LLC raised its holdings in shares of Healthcare Realty Trust Incorporated (NYSE:HR) by 11.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 41,624 shares of the real estate investment trust’s stock after acquiring an additional 4,249 shares during the quarter. Metis Global Partners LLC’s holdings in Healthcare Realty Trust were worth $706,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Capital Investment Advisors LLC raised its stake in Healthcare Realty Trust by 31.0% during the 4th quarter. Capital Investment Advisors LLC now owns 469,323 shares of the real estate investment trust’s stock valued at $7,955,000 after purchasing an additional 111,125 shares during the period. Cerity Partners LLC grew its holdings in Healthcare Realty Trust by 106.4% during the 3rd quarter. Cerity Partners LLC now owns 77,545 shares of the real estate investment trust’s stock valued at $1,407,000 after buying an additional 39,975 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of Healthcare Realty Trust during the third quarter valued at approximately $849,000. Stifel Financial Corp lifted its holdings in shares of Healthcare Realty Trust by 13.4% in the third quarter. Stifel Financial Corp now owns 84,728 shares of the real estate investment trust’s stock worth $1,538,000 after buying an additional 10,044 shares in the last quarter. Finally, Geneos Wealth Management Inc. bought a new position in shares of Healthcare Realty Trust during the fourth quarter worth $399,000.

Healthcare Realty Trust Trading Down 0.6 %

Shares of NYSE:HR opened at $16.69 on Wednesday. The company has a market cap of $5.86 billion, a price-to-earnings ratio of -9.38 and a beta of 0.94. Healthcare Realty Trust Incorporated has a 12 month low of $12.77 and a 12 month high of $18.90. The company has a 50-day moving average price of $16.63 and a 200 day moving average price of $17.36.

Healthcare Realty Trust (NYSE:HR) last issued its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. The business had revenue of $309.77 million for the quarter, compared to the consensus estimate of $303.81 million. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. The company’s quarterly revenue was down 6.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.39 earnings per share. As a group, equities analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current year.

Healthcare Realty Trust Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 19th. Shareholders of record on Monday, March 3rd will be paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 7.43%. The ex-dividend date of this dividend is Monday, March 3rd. Healthcare Realty Trust’s payout ratio is -69.66%.

Insider Buying and Selling at Healthcare Realty Trust

In other news, Director Peter F. Sr Lyle, Sr. acquired 10,000 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was acquired at an average price of $17.21 per share, with a total value of $172,100.00. Following the completion of the purchase, the director now directly owns 26,576 shares in the company, valued at approximately $457,372.96. This trade represents a 60.33 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.56% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on HR shares. Wedbush reiterated an “outperform” rating and issued a $16.00 price target on shares of Healthcare Realty Trust in a report on Thursday, February 20th. Scotiabank reduced their target price on Healthcare Realty Trust from $18.00 to $17.00 and set a “sector perform” rating on the stock in a report on Tuesday, February 25th. JPMorgan Chase & Co. lowered Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price target for the company. in a research note on Friday, December 20th. Jefferies Financial Group cut Healthcare Realty Trust from a “buy” rating to a “hold” rating and cut their price target for the company from $19.00 to $17.00 in a report on Thursday, January 2nd. Finally, StockNews.com cut Healthcare Realty Trust from a “hold” rating to a “sell” rating in a report on Wednesday. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $17.20.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.